Education
About Us
Working with TipRanks
Follow Us
ImmunityBio (IBRX)
NASDAQ:IBRX
ImmunityBio (IBRX) Ownership Overview
76.66% Insiders
2.65% Mutual Funds
2.22% Other Institutional Investors
3.76% ETFs
14.72% Public Companies and
Individual Investors
The ownership structure of ImmunityBio (IBRX) stock is a mix of institutional, retail, and individual investors. Approximately 8.63% of the company’s stock is owned by Institutional Investors, 76.66% is owned by Insiders, and 14.72% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 12, 2024 | Shiong Patrick Soon Founder, Executive Chairman, Global Chief Scientific And Medical Officer,director, >10% Owner | xxxxxxxxxxxxx | $230883862 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $84769 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $3127639 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $8812646 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 649,794,019 | Insider | 76.14% | 1,864,908,835 | |
| 16,705,181 | Institution | 1.96% | 47,943,869 | |
| 15,478,013 | Institution | 1.81% | 44,421,897 | |
| 7,397,492 | Institution | 0.87% | 21,230,802 | |
| 6,010,263 | Institution | 0.70% | 17,249,455 | |
| 3,442,440 | Institution | 0.40% | 9,879,803 | |
| 3,243,571 | Insider | 0.38% | 9,309,049 | |
| 1,904,812 | Institution | 0.22% | 5,466,810 | |
| 1,603,408 | Institution | 0.19% | 4,601,781 | |
| 1,221,734 | Institution | 0.14% | 3,506,377 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 15,478,013 | Institution | 1.81% | 44,421,897 | |
| 1,904,812 | Institution | 0.22% | 5,466,810 | |
| 1,603,408 | Institution | 0.19% | 4,601,781 | |
| 814,377 | Institution | 0.10% | 2,337,262 | |
| 716,465 | Institution | 0.08% | 2,056,255 | |
| 458,073 | Institution | 0.05% | 1,314,670 | |
| 418,769 | Institution | 0.05% | 1,201,867 | |
| 264,463 | Institution | 0.03% | 759,009 | |
| 181,435 | Institution | 0.02% | 520,718 | |
| 120,843 | Institution | 0.01% | 346,819 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,744,471 | Institution | 0.67% | 16,658,966 | |
| 5,732,605 | Institution | 0.67% | 18,860,270 | |
| 4,648,525 | Institution | 0.54% | 11,900,224 | |
| 3,882,089 | Institution | 0.45% | 11,141,595 | |
| 2,627,472 | Institution | 0.31% | 9,064,778 | |
| 2,474,222 | Institution | 0.29% | 8,140,190 | |
| 1,005,425 | Institution | 0.12% | 2,885,570 | |
| 742,772 | Institution | 0.09% | 2,154,039 | |
| 673,397 | Institution | 0.08% | 2,215,476 | |
| 661,396 | Institution | 0.08% | 2,175,993 |
FAQ
Who Owns ImmunityBio (IBRX)?
According to the latest TipRanks data, approximately 2.22% of the company's stock is held by institutional investors, 76.66% is held by insiders, and 14.72% is held by retail investors.
What percentage of ImmunityBio (IBRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.22% of ImmunityBio (IBRX) stock is held by institutional investors.
What percentage of ImmunityBio (IBRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.72% of ImmunityBio (IBRX) stock is held by retail investors.
Who owns the most shares of ImmunityBio (IBRX)?
Shiong Patrick Soon owns the most shares of ImmunityBio (IBRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.